Articles
Articles and analyses from the INET community on the key economic questions of our time.
When Economists Attack
How Gerald Friedman’s assessment of Bernie Sanders economic proposals prompted a rare public political spat among economists.
Towards a theory of shadow money
We Stopped Pfizer’s Tax Dodge, Now Let’s End the Buybacks
Industrial journalist Ken Jacobson and economist William Lazonick (both of the Academic-Industry Research Network), call for an end to stock market manipulation through buybacks.
In EU budget debates, ‘technocratic’ veil hides political choices
As the European Union Commission readies itself for a new round of budgetary recommendations, INET senior economist Orsola Costantini warns that that the debate over how those harsh fiscal constraints are to be determined is based on a formula that masks political choices as technocratic imperatives.
When Things Fall Apart
Refugees and The Economy: Lessons from History
What can we learn from the Vietnamese, Cuban, Rwandan, and Syrian refugees crisis?
Liquidity Trap & Excessive Leverage
How excessive debt hurts the economy and why to curb it.
The China Delusion
The current bout of exchange rate anxiety is really just a symptom of the fact that China’s transition from an export-led growth strategy to one propelled by domestic consumption is proceeding far less smoothly than hoped.
Professional Expertise or Politics Driving Economists’ View of Hillary and Bernie?
Bullet-point financial reform proposals are either too simple or too vague.
Let Them Drink Pollution?
Friendly Fire
The Sneaky Way Austerity Got Sold to the Public Like Snake Oil
A budget approach cloaked in the aura of science and technical jargon became a tool of manipulation.
U.S. Corporations Don’t Need Tax Breaks on Foreign Profits
Many Americans have expressed outrage over Pfizer’s plan, through its merger with Allergan, to move its tax home from the United States to Ireland. Now, in a New York Times op-ed, Carl Icahn, the billionaire corporate raider turned hedge fund activist, has joined the chorus. He labels the Pfizer-Allergan deal a “travesty,” blaming the U.S.’s “uncompetitive international tax system.”
RMB in SDR, Now What?
The American Dual Economy: Race, Globalization and the Politics of Exclusion
The United States economy has come apart, with the rich getting richer and workers’ incomes not advancing at all.